Diagnoses of attention-deficit/hyperactivity disorder (ADHD) have increased in many countries across all age groups, ...

The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of ...

IS ADHD a social construct? That’s what a new Channel 4 documentary will ask – and it’s hit a nerve for many. It comes amid ...

The FDA approved a new ADHD drug in July. The coverage says it's a non-stimulant, first-in-class, stimulant-like. I read all ...

An 18-year follow-up study published in Psychiatry Research provides evidence that children diagnosed with ...

Cognitive behavioral therapy (CBT) is a vetted, evidence-based psychosocial treatment for adult ADHD. Such evidence-based status is established chiefly by way of randomized controlled clinical trials.

ADHD, which stands for attention-deficit hyperactivity disorder, is a neurodevelopmental disorder that’s typically diagnosed in children. But according to data from the National Center for Health ...

New research reveals ADHD isn't one-size-fits-all — covering social media's specific role, why medication rarely 'stops ...

Diagnoses for attention deficit hyperactivity disorder (ADHD) have increased in many countries across all age groups, our ...

ADHD is usually associated with being careless, impulsive and having difficulty concentrating. New research focused on ADHD in adults indicates a greater number of cognitive and motor symptoms, and ...

The FDA has approved Simtriyo (centanafadine) as the first norepinephrine, dopamine, serotonin reuptake inhibitor for adult and pediatric ADHD.

Adult Attention-Deficit/Hyperactivity Disorder (ADHD) and Generalised Anxiety Disorder (GAD) are both very common mental ...